Journal
CLINICAL CASE REPORTS
Volume 5, Issue 1, Pages 18-21Publisher
WILEY
DOI: 10.1002/ccr3.748
Keywords
Enoximone; nitric oxide; neonatal transport; persistent pulmonary hypertension of the newborn; phosphodiesterase inhibitor
Categories
Ask authors/readers for more resources
Severe Persistent pulmonary hypertension of the newborn (PPHN) can be effectively treated with a PDE3 inhibitor as first-line treatment during neonatal transport when iNO is not readily available. Starting iNO as soon as possible is strongly advised because of the complementary actions of both therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available